Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice

Authors

• Ivana Reidel, Beckman Research Institute of City of Hope, USAFollow
• Gabriela M. . Escalante, Department of Immuno-Oncology, Beckman Research Institute of City of Hope, USA
• Simeon Cua, Department of Immuno-Oncology, Beckman Research Institute of City of Hope, USA
• Brenda Alvarado, Department of Immuno-Oncology, Beckman Research Institute of City of Hope, USA
• Esther Rodriguez, Department of Immuno-Oncology, Beckman Research Institute of City of Hope, USA
• Cloe Zimmerman, Department of Immuno-Oncology, Beckman Research Institute of City of Hope, USA
• Murali Muniraju, Department of Immuno-Oncology, Beckman Research Institute of City of Hope, USA
• Lorraine Z. Mutsvunguma, Department of Immuno-Oncology, Beckman Research Institute of City of Hope, USA
• He . Li, Vaccine and Gene Therapy Institute, Oregon Health & Science University, USA
• Aparna N. Govindan, Mayo Clinic School of Health Sciences, USA
• Michael K. . Axthelm, Oregon National Primate Research Center, Oregon Health & Science University, USA
• Scott W. Wong, Oregon National Primate Research Center, Oregon Health & Science University, USA
• Javier Gordon Ogembo, Department of Immuno-Oncology, Beckman Research Institute of City of Hope, USA.

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Ivana Reidel, Gabriela M. . Escalante, Simeon Cua, Brenda Alvarado, Esther Rodriguez, Cloe Zimmerman, Murali Muniraju, Lorraine Z. Mutsvunguma, He . Li, Aparna N. Govindan, Michael K. . Axthelm, Scott W. Wong, and Javier Gordon Ogembo, "Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/79